期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

HLA-A2限制性CTL表位HPV18E7_(7-15)分子修饰肽的免疫原性鉴定

Identification on Immunogenicity of Molecular Modification of the Cytotoxic T Lymphocyte Epitope HPV18E7_(7-15) Restricted by HLA-A2
下载PDF
导出
摘要 目的:对HLA-A2限制性细胞毒性T淋巴细胞(cytotoxic T lymphocyte,CTL)表位HPV18E77-15进行氨基酸置换修饰,探讨修饰肽的免疫原性。方法:采用细胞毒实验(51Cr释放法),以包被了九肽的T2细胞作为靶细胞,以九肽诱导的HLA-A2阳性人外周血单个核细胞为效应细胞,观察目标肽是否具有诱导特异性CTL杀伤效应。结果:修饰肽符合HLA-A2分子限制性细胞毒性T细胞的表位要求,具有特异性细胞毒性T细胞诱导活性。结论:修饰肽具有较强的抗原性,可以作为高危型HPV感染治疗性肽疫苗分子设计的候选表位。 Objective：To investigate the immunogenicity of peptide modified by amino acid substitution for the cytotoxic T lymphocytes（CTLs） epitope HPV18E77-15 restricted by HLA-A2. Methods：51Cr release assay was used to determine their abilities of inducing the generation of specific CTLs. Results：The modified peptide TLQDIVLHV met the requirements of HLA-A2-restricted CTL epitopes and had the abilitiy of inducing the generation of specific CTLs. Conclusion：The modified peptide TLQDIVLHV may have better antigenicity and affinity to HLA-A2,and can be used as one of the HLA-A2 restricted candidate epitopes for therapeutic peptide vaccine against HPV infection.
作者 邵笑红 欧荣英 徐云升 张学奇 蔡剑峰 李秉煦
机构地区 温州医学院附属第一医院皮肤性病科
出处 《浙江中西医结合杂志》 2010年第12期739-741,共3页 Zhejiang Journal of Integrated Traditional Chinese and Western Medicine
基金 温州市科技计划项目(No.Y20080171 Y20080146)
关键词 人乳头状瘤病毒 E7抗原 表位 HLA-A2 CTL 免疫原性 分子修饰 papillomavirus human E7 antigen epitopes HLA-A2 cytotoxic Tlymphocyte molecular modification
分类号 R392 [医药卫生—免疫学]
  • 相关文献

参考文献8

  • 1Smahel M,Tejklova P,Smahelova J,et al.Mutation in the immunodominant epitope of the HPV16 E7 oncoprotein as a mechanism of tumor escape[J].Cancer Immunol Immunother,2008,57(6):823-831.
  • 2Nilres K,Hohn H,Pilch H,et al.Human papillomavirus type 16E7 peptide-directed CD8-T cells front patients with cervical cancer are cross-reactive with the corenavirus NS2 protein[J].J Viml,2003,77(9):5464-5474.
  • 3Khan MJ,Castle PE,Lorinez AT,et al.The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus(HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice[J].J Natl Cancer Inst,2005,97(14):1072-1079.
  • 4欧荣英,徐云升,林治华,郝飞,倪兵,吴玉章.十肽表位HPV-16E7_(11-20)氨基酸置换修饰的研究[J].中华微生物学和免疫学杂志,2006,26(11):990-993. 被引量：6
  • 5Wiethe C,Dittmar K,Doan T,et al.Provision of 4-1BB ligand enhances effector and memory CTL responses generated by immunization with dendritic cells expressing a human tumor-associated antigen[J].J Immunol,2003,170(6):2912-2922.
  • 6田启龙.穿刺置疣术治疗尖锐湿疣97例对比观察[J].中国艾滋病性病,2009,15(1):77-78. 被引量：3
  • 7Hung CF,Monie A,Alvarez RD,et al.DNA vaccines for cervical cancer:from bench to bedside[J].Exp Mol Med,2007,39(6):679-689.
  • 8Lowy DR,Schiller JT.Prophylactic human papillomavirus vaccines[J].J Clin Invest,2006,116(5):l167-1173.

二级参考文献12

  • 1李艳佳,齐凤英,左连富,郭建文,张俊峰,宣晓梅,陈兴宽.人乳头瘤病毒16型E7基因修饰小鼠骨髓树突状细胞诱导的细胞免疫应答[J].中华微生物学和免疫学杂志,2005,25(2):136-136. 被引量：2
  • 2Nilges K,Hohn H,Pilch H,et al.Human papillomavirus type 16E7peptide-directed CD8^+ T cells from patients with cervical cancer are cross-reactive with the coronavirus NS2 protein.J Virol,2003,77(9):5464-5474.
  • 3Okubo M,Saito M,Inoku H,et al.Analysis of HLA-DRB1 * 0901-binding HPV-16 E7 helper T cell epitope.J Obstet Gynaecol Res,2004,30(2):120-129.
  • 4Kotecha MT,Afghan RK,Vasilikopoulou E,et al.Enhanced tumour growth after DNA vaccination against human papillomavirus E7 oncoprotein:evidence for tumour-induced immune deviation.Vaccine,2003,21(19-20):2506-2515.
  • 5Herd KA,Harvey T,Khromykh AA,et al.Recombinant Kunjin virus replicon vaccines induce protective T-cell immunity against human papillomavirus 16 E7-expressing tumour.Virology.2004,319(2):237-248.
  • 6Liu XS,Xu Y,Hardy L,et al.IL-10 mediates suppression of the CD8 Tcell IFN-gamma response to a novel viral epitope in a primed host.J Immunol,2003,171(9):4765-4772.
  • 7Hoffmann TK,Donnenberg AD,Finkelstein SD,et al.Frequencies of tetramer^+ T cells specific for the wild-type sequence p53(264-272) peptide in the circulation of patients with head and neck cancer.Cancer Res,2002,62(12):3521-3529.
  • 8Wiethe C,Dittmar K,Doan T,etal.Provision of 4-1BB ligand enhances effector and memory CTL responses generated by immunization with dendritic cells expressing a human tumor-associated antigen.J Immunol,2003,170(6):2912-2922.
  • 9Khammanivong V,Liu XS,Liu WJ,et al.Paucity of functional CTL epitopes in the E7 oncoprotein of cervical cancer associated human papillomavirus type 16.Immunol Cell Biol,2003,81(1):1-7.
  • 10Cassetti MC,McElhiney SP,Shahabi V,et al.Antitumor efficacy of Venezuelan equine encephalitis virus replicon particles encoding mutated HPV16 E6 and E7 genes.Vaccine,2004,22(3-4):520-527.

共引文献7

浙江中西医结合杂志
2010年 第12期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部